n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.
about
Omega 3 fatty acids for prevention and treatment of cardiovascular diseaseα-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysisSecondary prevention of coronary heart disease in the elderlyN-6 and N-3 fatty acid cholesteryl esters in relation to fatal CHD in a Dutch adult population: a nested case-control study and meta-analysisThe cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acidEffects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial.Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.Long term adherence to dietary recommendations after inpatient rehabilitation: prospective follow up study of patients with coronary heart disease.Biological Properties of Fucoxanthin in Oil Recovered from Two Brown Seaweeds Using Supercritical CO2 Extraction.Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor.Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules.Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.Chronic Omega-3 Polyunsaturated Fatty Acid Treatment Variably Affects Cellular Repolarization in a Healed Post-MI Arrhythmia Model.How can research on plants contribute to promoting human health?Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol.Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort study.
P2860
Q24245810-5BE7491D-AC96-4AB2-A977-7BA7E3F38722Q24612659-505043D1-ABAC-4061-8420-35D6637EA30FQ28217741-3F90075A-647B-4AE1-8804-00623D051118Q28383694-34B18588-7F19-4E4E-8ACE-54272C48D905Q34338649-5D4A74A5-0D48-45C9-90BE-1FB4D19A35F8Q34356824-A967AC47-9124-4625-B5EA-D56E284E73C5Q34681730-24DD6B49-80F6-4EFF-9066-B15EF2BA9763Q35771707-40C7EF71-BCCD-493B-A713-9E02D3352581Q35790728-820A1027-9269-4D84-8220-86A25EDA832CQ35855795-ABDAA518-03B7-4892-AADD-0D4F135E6725Q36957089-3D306712-4465-405D-B4BD-9203FA5A1674Q36974431-FC33E976-14D1-449D-A136-68A4CEEB57C9Q36999779-B1F8EF3D-4DB1-4B50-959C-12CCB4A40AE0Q37876589-59FA3BB1-45A5-41E1-A44E-29C1A624804CQ47118074-2331B8A3-A931-4201-8FB9-05CA533910F6Q47748477-40CF8D44-0B75-4ED5-8D24-DC08032A0D62
P2860
n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@en
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@nl
type
label
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@en
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@nl
prefLabel
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@en
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@nl
P2093
P356
P1476
n-3 Fatty acids and 5-y risks ...... with coronary artery disease.
@en
P2093
Arja T Erkkilä
Kalevi Pyörälä
Matti I J Uusitupa
Seppo Lehto
P356
10.1093/AJCN/78.1.65
P407
P577
2003-07-01T00:00:00Z